The Risk of Cancer in Patients With Psoriasis | Zendy

Zelma C. Chiesa Fuxench | Zendy; Daniel B. Shin | Zendy; Alexis Ogdie Beatty | Zendy; Joel M. Gelfand | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

The Risk of Cancer in Patients With Psoriasis

Author(s) -

Zelma C. Chiesa Fuxench,

Daniel B. Shin,

Alexis Ogdie Beatty,

Joel M. Gelfand

Publication year - 2015

Publication title -

jama dermatology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.128

H-Index - 166

eISSN - 2168-6084

pISSN - 2168-6068

DOI - 10.1001/jamadermatol.2015.4847

Subject(s) - medicine , psoriasis , acitretin , ustekinumab , etanercept , adalimumab , population , cancer , infliximab , skin cancer , dermatology , disease , rheumatoid arthritis , environmental health

The risk of cancer in patients with psoriasis remains a cause of special concern due to the chronic inflammatory nature of the disease, the use of immune-suppressive treatments and UV therapies, and the increased prevalence of comorbid, well-established risk factors for cancer, such as smoking and obesity, all of which may increase the risk of carcinogenesis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research